Abstract
Neutropenic enterocolitis (NE) must be recognized in patients with fever, neutropenia, and abdominal pain. Classically, NE has been described in patients with hematologic malignancies treated with intensive chemotherapy. Current interest in NE has increased due to recent cases associated with newer, more intensive chemotherapy in solid tumors. This review discusses pathology, clinical presentation, and treatment of NE. Ultrasonography or CT scans are the best radiographic studies to confirm the diagnosis. Management options, including antimicrobial therapy, surgery, and supportive care, are discussed. Chemotherapy incorporating the taxane family of drugs (paclitaxel and docetaxel) associated with NE is also reviewed with observations regarding the earlier onset of the disease in the first weeks following chemotherapy. Even with currently recommended therapy, a high mortality rate, approximating 45%, can occur. Best outcomes for NE rely upon understanding of risks for the condition, prompt empiric therapy with broadspectrum antimicrobial agents, systemic antifungal therapy, and meticulous attention to supportive care.
Similar content being viewed by others
References and Recommended Reading
Alt B, Glass NR, Sollinger H: Neutropenic enterocolitis in adults. Review of literature and assessment of surgical intervention. Am J Surg 1985, 149: 405–408.
WilliamsN: Neutropenic colitis: a continuing surgical challenge. Br J Surg 1997, 84:1200.
Chirletti P, Barillari P, Sammartino P, et al.: The surgical choice in neutropenic patients with hematological disorders and acute abdominal complications. Leuk Lymphoma 1993, 9:237–241.
Gorschluter M, Glashmacher A, Han C, et al.: Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001, 33:786–791. Good review.
Kirkpatrick ID, Greenberg HM: Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology 2003, 226:668–674. Great source of information.
Cooke JV: Acute leukemia in children. JAMA 1933, 101:432–435.
Moir DH, Bale PM: Necropsy findings in childhood leukaemia, emphasizing neutropenic enterocolitis and cerebral calcification. Pathology 1976, 8:247–258.
Mulholland MW, Delaney JP: Neutropenic colitis and aplastic anaemia, a new association. Ann Surg 1983, 197:84–90.
Katz JA, Wagner ML, Gresik MV, et al.: An 18-year experience and postmortem review. Cancer 1990: 65:1041–1047.
Urbach DR, Rotstein OD: Typhlitis. Can J Surg 1999, 42:415–419. Essential surgical information.
Gorshluter M, Mey U, Strehl J, et al.: Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 2005, 75:1–13. Excellent review of all historical and modern cases and trials regarding NE.
Cordona, AF, Ramos PL, Casasbuenas A: From case reports to systematic reviews in neutropenic enterocolitis, Eur J Haematol 2005, 75:445–446. Concise letter with regional information.
Kunkel JM, Rosenthal D: Management of the ileocecal syndrome: neutropenic colitis. Dis Colon Rectum 1986, 29:196–199.
Rifkin GD: Neutropenic enterocolitis and Clostridium septicum infection in patients with agranulocytosis. Arch Intern Med 1980, 40:834–835.
Gomez L, Martino R, Rolston KV, Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases. Clin Infect Dis 1998, 27:695–699.
Wade DS, Nava HR, Douglass HOJ, Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 1992, 69:17–23.
Yuen KY, Woo PC, Liang RH, et al.: Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn Microbiol Infect Dis 1998, 30:75–81.
Sloas MM, Flynn PM, Kaste SC, Patrick CC: Typhlitis in children with cancer: a 30 year experience. Clin Infect Dis 1993, 17:484–490.
Pokorney BH, Jones JM, Shaikh BS, Aber RC: Typhlitis a treatable cause of recurrent septicemia. JAMA 1980, 243: 682–683.
Koransky JR, Stargel MD, Dowell VR: Clostridium septicum bacteremia. Its clinical significance. Am J Med 1979, 66:63–66.
Koea JB, Shaw JHF: Surgical management of neutropenic enterocolitis. Br J Surg 1989, 75:821–824.
Varki AP, Armitage JO, Feagler JR: Typhlitis in acute leukemia: successful treatment by early surgical intervention. Cancer 1979, 43:695–697.
Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH: The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 1986, 57:603–609.
Vohra R, Prescotti RJ, Banerjee SS: Management of neutropenic colitis. Surg Oncol 1992, 1:11–15.
Weinberger M, Hollingsworth H, Feuerstein IM, et al.: Successful surgical management of neutropenic enterocolitis in two patients with severe aplastic anemia. Case reports and review of the literature. Arch Intern Med 1993, 153:107–113.
Buchheidt, D, Bohme A, Cornely OA, et al.: Diagnosis and treatment of documented infections in neutropenic patients: Recommendations of the Infectious Disease Working Party(AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003, 82(Suppl 2):S127-S132. Concise antimicrobial information.
Van de WeteriMD, Kuijpers TW, Taminiau JA, et al.: Pseudomembranous and neutropenic enterocolitis in pediatric oncology patients. Support Care Cancer 2003, 11:581–586.
Alexander JE, Williamson SL, Seibert JJ, et al.: The ultrasonic diagnosis of typhlitis (neutropenic colitis). Paedriatr Radiol 1988, 18: 200–204.
Shaked A, Shinar E, Freund H: Neutropenic typhlitis. A plea for conservation. Dis Colon Rectum 1983, 25:351–352.
McNamara MJ, Chambers AG, Morgan M, Smith SEW: Typhlitis in acute childhood leukaemia: radiological features. Clin Radiol 1986, 37:83–86.
Cartoni C, Dragoni F, Micozzi A, et al.: Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol 2001, 19:756–751. Good source regarding ultrasound findings.
Gorshluter M, Marklein G, Hofling K, et al.: Abdominal infections in patents with acute leukaemia: a prospective study applying ultrasonography and microbiology. Br J Haematol 2002, 117:351–358. Worthy of review.
Taylor AJ, Dodds WJ, Gonyo JE, Komrowshi RA: Typhlitis in adults. Gastrointest Radiol 1985, 10:363.
Del Fava RL, Cronin TG: Typhlitis complicating leukemia in an adult: barium enema findings. AJR Am J Roentgenol 1977, 129:347–348.
Gorschluter M, Mey U, Strehl J, et al.: Invasive fungal infections in neutropenic enterocolitis: A systematic review of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis. 2006, 6(1):35 [E pub ahead of print]. Most up to date evidence-based compilation regarding all aspects of NE.
Hughes WT, Armstrong D, Bodey GP, et al.: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34:730–751. Great source for supportive measures.
NCCN ractice guidelines for fever and neutropenia. National Comprehensive Cancer Network. Oncology (Huntingt) 1999, 13:197–257.
SC, Fakhry K, Bass BL, Napolitano LM: Neutropenic enterocolitis in adults: case series and review of the literature. Digest Dis Sci 2005, 50:215–220. Good compilation of information with cases.
Ozer H, Armitage JO, Beenntt CL, et al.: 2000 Update of recommnendations for the use of hematopoietic colony stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 2000, 18:3558–3585. Important clinical application for prevention.
Kouroussis C, Samonis G, Androulakis N, et al.: Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. Am J Clin Oncol 2000, 23:309–313. An important paper providing new incidence information.
Pestalozzi BC, Sotos GA, Choyke PL, et al.: Typhlitis resulting from treatment with Taxol and doxorubicin in patients with metastatic breast cancer. Cancer 1993, 71:1797–1800.
Millward MJ, Zalcberg J, Bishop JF, et al.: Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer. J Clin Oncol 1997, 15:750–758.
D’Amato G, Rocha Lima C, Mahany JJ, et al.: Neutropenic enterocolitis (typhlitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature. Lung Cancer 2004, 44:381–390. A must read; great source of information and case review.
Stemmler HJ, Kenngotte S, Diepolder H, Heinemann V: Gastrointestinal toxicity associated with weekly docetaxel treatment. Ann Oncol 2002, 13:978–981.
Polee, MB, Verweij J, Siersema PD, et al.: Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. Eur J Cancer 2002, 38:1495–1500.
Ibrahim NK, Sahin AA, Dubrow RA, et al.: Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet 2000, 355:281–283.
Cardenal F, Montes A, Liort G, et al.: Typhlitis associated with docetaxel treatment. J Natl Cancer Inst 1996, 88:1078–1079.
Petrylak DP, Macarthur RB, O’Connor J, et al.: Phase 1 trial of docetaxel with estramustine in androgen-independent prostate cancer. J Clin Oncol 1999, 17:958–967.
Pagani O, Sess C, Martinelli G, et al.: Dose-.nding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer. Ann Oncol 1999, 10:539–545.
Gadducci A, Gargini A, Palla E, et al.: Neutropenic enterocolitis in an advanced epithelial ovarian cancer patient treated with paclitaxel/platinum-based chemotherapy: a case report and review of the literature. Anticancer Res 2005, 25:2509–2514.
Furonaka M, Miyazaki M, Nakajima M, et al.: Neutropenic enterocoloitis in lung cancer: a report of two cases and a review of the literature. Intern Med 2005, 44:476–470.
Rose PG, Piver MS: Case report: intestinal perforation fecondary to oaclitaxel. Gyn Oncol 1995, 57:270–272.
Seewaldt, VL, Cain JM, Goff BA, et al.: A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer. Gynecol Oncol 1997, 67:137–140.
Hruban RH, Yardley JH, Donehower RC, Boitnott JK: Taxol toxicity. Cancer 1989, 63:1933–1950.
Kronawitter U, Kemeny NE, Blumgart L: Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-.uorouracil and leucovorin—a case report. Cancer 1997, 80:656–660.
Clemons M, Valle J, Harris M, et al.: Citrobacter fruendii and fatal neutropenic enterocolitis following adjuvant chemotherapy or breast cancer. Ann Oncol 1997, 8:405.
Vlasveld LT, Ten Bokkel HW, Rodenhuis S: Neutropenic enterocolitis in a woman with ovarian cancer after treatment with high-dose carboplatin and granulocyte macrophage-colony stimulating factor. Neth J Med 1990, 37:158–161.
Hayes, D. Leonardo JM: Neutropenic enterocolitis in a woman treated with 5-.uorouracil and leucovorin for colon carcinoma. NC Med J 2002, 63:132–134.
Ferrazzi E, Toso S, Zanotti M, Giuliano G: Typhlitis (neutropenic enterocolitis) after a single dose of vinorelbine. Cancer Chemother Pharmacol 2001, 47:277–279.
Avigan D, Richardson P, Elias A, et al.: Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors. Cancer 1998, 83:409–414.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bremer, C.T., Monahan, B.P. Necrotizing enterocolitis in neutropenia and chemotherapy: A clinical update and old lessons relearned. Curr Gastroenterol Rep 8, 333–341 (2006). https://doi.org/10.1007/s11894-006-0055-z
Issue Date:
DOI: https://doi.org/10.1007/s11894-006-0055-z